Clinical ResearchHeart Rhythm DisorderMyocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death
Heart Rhythm Disorder
Under an Elsevier user license
open archive
Key Words
arrhythmia
cardiomyopathy
heart arrest
magnetic resonance imaging
Abbreviations and Acronyms
CMRI
cardiac magnetic resonance imaging
ICD
implantable cardioverter-defibrillator
ICM
ischemic cardiomyopathy
IQR
interquartile range
LGE
late gadolinium enhancement
LV
left ventricular
LVEF
left ventricular ejection fraction
NICM
nonischemic cardiomyopathy
NYHA
New York Heart Association
SCD
sudden cardiac death
Cited by (0)
Dr. Iles is supported by a National Health and Medical Research Council Post Graduate Research Scholarship, Melbourne, Australia. Dr. Pfluger is supported by a research grant from Swiss National Science Foundation SNSF, Bern, Switzerland. Dr. Butler is supported by an Australian Post-Graduate Award, Monash University, Melbourne, Australia. Dr. Kistler is the recipient of a research investigatorship from the Cardiac Society of Australasia. Dr. Taylor is supported by a National Health and Medical Research Council program grant, and an Australian National Heart Foundation project grant. All other authors have reported that they have no relationships to disclose.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.